Skip to content

Performance of the Acoustic Based CADScor System in Coronary Artery Disease

Performance of the Acoustic Based CADScor System in Coronary Artery Disease

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06655779
Enrollment
200
Registered
2024-10-23
Start date
2024-11-30
Completion date
2026-03-31
Last updated
2024-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angina (stable), Coronary Artery Disease

Keywords

CADScore

Brief summary

The purpose of this study is to determine if the CAD Score, collected from the CADscore system, performs as well as the Coronary CTA in determining Coronary Artery Disease, in low to intermediate risk patients that are referred for coronary CTA.

Interventions

DIAGNOSTIC_TESTAcoustic Detection of Blood Flow

Subject will have the acoustic device scoring performed prior to a Coronary CTA. No treatment decisions will be based upon the acoustic device score.

Sponsors

INTEGRIS Baptist Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Inclusion: * Signed ICF * Male or female, aged 30 years or above * Symptoms suggestive of stable coronary artery disease * No history of coronary artery disease(prior myocardial infarction, percutaneous coronary intervention or coronary artery bypass graft). Exclusion: * Asymptomatic for angina or chest pain * Implanted donor heart * Previous Coronary Artery Bypass Graft(CABG) * Previous Coronary Stenting or known CAD * Arrhythmia causing non-sinus rhythm * Fragile or compromised skin, or abnormal anatomy or significant operation scars in the fourth left int3er Costal 9IC4-L) recording area * Implanted mechanical heart or mechanical heart pump * Implanted pacemaker or Cardioverter Defibrillator(ICD), other implanted active electronics or act5ive electronic support equipment closer than 50 cm to the CADScore System.

Design outcomes

Primary

MeasureTime frameDescription
Primary ObjectiveFrom enrollment through 1 yearTo determine that the sensitivity of the CAD score in low to intermediate-risk patients referred for coronary CTA in non-inferior to the device specified sensitivity at 89%.

Countries

United States

Contacts

Primary ContactJill Fife, RN
bethany.fife@integrishealth.org405-951-8607
Backup ContactLinda Pitchford, RN, APRN
linda.pitchford@integrishealth.org405-949-3648

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026